8/22/25 16:30 | 8/20/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Chase William J | MA | D | | 1 | P | 1,003 | 10.03 | 0 | 100 | 288 | 135 | D | | | | | | | | | | | | | | |
8/21/25 17:27 | 8/19/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Patel Rajiv A | CA | H | Member o | 1 | S.m | -191,214 | 56.14 | 0 | -3,406 | | 3,477 | I | | | | | | | | | | | | | | |
8/21/25 17:27 | 8/19/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Farallon Partners L L C/Ca | CA | TH | Member o | 1 | S.m | -191,214 | 56.14 | 0 | -3,406 | | 3,477 | I | | | | | | | | | | | | | | |
8/20/25 14:49 | 8/18/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | 1 | M.d | 194 | 5.43 | 0 | 36 | 13 | 307 | D | | | | | | | | | | | | | | |
8/20/25 14:39 | 8/18/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | 1 | M.d | 78 | 5.43 | 0 | 14 | 21 | 82 | D | | | | | | | | | | | | | | |
8/20/25 11:57 | 8/18/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | 1 | M.d | 78 | 5.43 | 0 | 14 | 26 | 70 | D | | | | | | | | | | | | | | |
8/20/25 10:28 | 8/18/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rocklin Amy M | MI | O | GC | 1 | M.d | 56 | 5.43 | 0 | 10 | 31 | 44 | D | | | | | | | | | | | | | | |
8/20/25 10:23 | 8/18/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Moylan John Patrick | MI | O | Chief Ac | 1 | M.d | 11 | 5.43 | 0 | 2 | 16 | 14 | D | | | | | | | | | | | | | | |
8/15/25 16:33 | 8/13/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | 2 | S | -690 | 71.39 | 0 | -10 | | 112 | D | | | | | | | | | | | | | | |
8/15/25 16:07 | 8/13/25 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jimenez Freddy A. | NJ | O | SVP,GC | 1 | S | -19 | 24.77 | 0 | -1 | | 35 | D | | | | | | | | | | | | | | |
8/14/25 18:01 | 8/12/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Erickson Michael G | ME | O | EVP | 1 | S | -264 | 649.79 | 0 | 0 | | 11 | D | | | | | | | | | | | | | | |
8/13/25 17:17 | 8/11/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | 4 | S.d | -7,990 | 357.29 | 0 | -22 | | 18 | D | | | | | | | | | | | | | | |
8/13/25 17:17 | 8/12/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | 4 | M.d | 7,990 | 357.29 | 0 | 22 | | 18 | D | | | | | | | | | | | | | | |
8/12/25 17:00 | 8/8/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | 2 | M.dm | 4,779 | 431.17 | 0 | 11 | | 6 | D | | | | | | | | | | | | | | |
8/12/25 17:00 | 8/8/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | 2 | S.dm | -4,779 | 431.17 | 0 | -11 | | 6 | D | | | | | | | | | | | | | | |
8/12/25 17:00 | 8/8/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | 3 | M.d | 20,586 | 350.69 | 0 | 59 | 237 | 83 | D | | | | | | | | | | | | | | |
8/11/25 18:00 | 8/7/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Emerson Andrew | ME | O | EVP,CFO, | 1 | M.d | 262 | 141.60 | 0 | 2 | 91 | 4 | D | | | | | | | | | | | | | | |
8/8/25 20:37 | 8/6/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | 2 | M.d | 7,604 | 452.00 | 0 | 17 | | 8 | D | | | | | | | | | | | | | | |
8/8/25 20:37 | 8/6/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | 2 | S.d | -7,604 | 452.00 | 0 | -17 | | 8 | D | | | | | | | | | | | | | | |
8/6/25 09:00 | 8/5/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | 1 | P | 50 | 0.6400 | 0 | 78 | 2 | 3,341 | D | | | | | | | | | | | | | | |
8/6/25 09:00 | 8/5/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | 2 | P | 57 | 0.6331 | 0 | 91 | 3 | 3,652 | D | | | | | | | | | | | | | | |
7/25/25 16:05 | 7/23/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dulac Edward J III | MA | O | EVP,CFO | 1 | S | -105 | 14.02 | 0 | -7 | | 106 | D | | | | | | | | | | | | | | |
7/17/25 16:09 | 7/15/25 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Buechler Kenneth F | CA | D | | 1 | M.d | 145 | 15.74 | 0 | 9 | 10 | 102 | D | | | | | | | | | | | | | | |
7/3/25 16:11 | 7/1/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | 1 | S | -10 | 9.82 | 0 | -1 | | 95 | D | | | | | | | | | | | | | | |
7/3/25 16:07 | 7/2/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dube Michael P | MA | O | VP,Chief | 1 | S | -25 | 9.95 | 0 | -3 | | 57 | D | | | | | | | | | | | | | | |
7/2/25 17:50 | 6/30/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goodman Jesse | MA | D | | 1 | S.m | -29 | 9.40 | 0 | -3 | | 24 | D | | | | | | | | | | | | | | |
7/1/25 16:59 | 6/27/25 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Demski Martha J | CA | D | | 1 | S | -41 | 5.06 | 0 | -8 | | 12 | D | | | | | | | | | | | | | | |
6/17/25 16:31 | 6/13/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | 2 | S | -950 | 79.20 | 0 | -12 | | 93 | D | | | | | | | | | | | | | | |
6/13/25 13:05 | 6/11/25 | ICCC | Immucell Corp /De/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Basse Gloria F | ME | D | | 1 | M.d | 17 | 4.81 | 0 | 4 | | 4 | D | | | | | | | | | | | | | | |
6/12/25 17:09 | 6/12/25 | ICCC | Immucell Corp /De/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gathagan Bryan K. | ME | D | | 1 | P | 6 | 6.32 | 0 | 1 | | 1 | D | | | | | | | | | | | | | | |
6/11/25 16:33 | 6/9/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McHugh Julie | MA | D | | 1 | S | -424 | 81.62 | 0 | -5 | | 26 | D | | | | | | | | | | | | | | |
6/11/25 16:32 | 6/9/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | 2 | M.d | 4,039 | 74.05 | 0 | 55 | 159 | 89 | D | | | | | | | | | | | | | | |
6/11/25 16:32 | 6/9/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | 2 | S.d | -4,039 | 74.05 | 0 | -55 | | 89 | D | | | | | | | | | | | | | | |
6/6/25 16:05 | 6/4/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vos Ellen O'Connor | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 5 | 8 | 74 | D | | | | | | | | | | | | | | |
6/6/25 07:53 | 6/4/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ragard John Phillip | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 5 | 4 | 135 | D | | | | | | | | | | | | | | |
6/5/25 16:15 | 6/4/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cavanaugh Stefanie L. | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 6 | 8 | 79 | D | | | | | | | | | | | | | | |
6/5/25 16:06 | 6/4/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Herchuk Jannie Prestridge | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 8 | 11 | 83 | D | | | | | | | | | | | | | | |
6/5/25 16:06 | 6/4/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Parnell Winfred | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 5 | 8 | 71 | D | | | | | | | | | | | | | | |
6/5/25 16:05 | 6/4/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Beausang Ellen | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 5 | 300 | 6 | D | | | | | | | | | | | | | | |